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Abstract
Background: SurA is a periplasmic peptidyl-prolyl isomerase (PPIase) and chaperone of Escherichia coli and other Gram-
negative bacteria. In contrast to other PPIases, SurA appears to have a distinct role in chaperoning newly synthesized porins
destined for insertion into the outer membrane. Previous studies have indicated that the chaperone activity of SurA rests in
its ‘‘core module’’ (the N- plus C-terminal domains), based on in vivo envelope phenotypes and in vitro binding and
protection of non-native substrates.
Methodology/Principal Findings: In this study, we determined the components of SurA required for chaperone activity
using in vivo phenotypes relevant to disease causation by uropathogenic E. coli (UPEC), namely membrane resistance to
permeation by antimicrobials and maturation of the type 1 pilus usher FimD. FimD is a SurA-dependent, integral outer
membrane protein through which heteropolymeric type 1 pili, which confer bladder epithelial binding and invasion
capacity upon uropathogenic E. coli, are assembled and extruded. Consistent with prior results, the in vivo chaperone
activity of SurA in UPEC rested primarily in the core module. However, the PPIase domains I and II were not expendable for
wild-type resistance to novobiocin in broth culture. Steady-state levels of FimD were substantially restored in the UPEC surA
mutant complemented with the SurA N- plus C-terminal domains. The addition of PPIase domain I augmented FimD
maturation into the outer membrane, consistent with a model in which domain I enhances stability of and/or substrate
binding by the core module.
Conclusions/Significance: Our results confirm the core module of E. coli SurA as a potential target for novel anti-infective
development.
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Introduction
Integrity of the outer membrane (OM) of Gram-negative bacteria
relies on the coordinated expression, maturation, and insertion of
lipopolysaccharide and a number of integral membrane proteins. A
major subset of OM proteins (OMPs), existing in monomeric or
multimeric forms, adopt pore structures upon their insertion into the
membrane. Recent studies have informed a model for the process by
which these porins traverse the periplasm and reach their destination
in the OM. Nascent polypeptides destined for OM insertion enter
the periplasm via the Sec translocon as the canonical signal sequence
is cleaved. Hydrophobic portions of the primary sequence, which are
common to integral OM proteins, might be expected to require
protection by chaperones during transit through the periplasm. The
protected polypeptides are delivered to an OM protein assembly
complex anchored by BamA (also known as YaeT) [1–3], which
coordinates the process of insertion through incompletely under-
stood mechanisms.
Multiple lines of evidence implicate the periplasmic peptidyl-
prolyl isomerase (PPIase) SurA in the chaperoning of b-barrel
porins through the periplasm. At least three families of PPIases are
encoded by Escherichia coli K-12; representative periplasmic
proteins are the cyclophilin PpiA [4], the FK binding protein-
like isomerase FkpA [5], and two parvulin domain-containing
isomerases, SurA and PpiD [6–8]. These proteins feature in
common one or more PPIase domains that catalyze the in vitro
isomerization of proline bonds [9]. Though FkpA also exhibits
chaperone activity [10,11], SurA is uniquely positioned as a
facilitator of periplasmic transit of nascent outer membrane porins.
The relative lack of two major OMPs, OmpA [6] and LamB [6,12],
in surA mutants of E. coli K-12 was reported by two groups in 1996.
More recently, we demonstrated that the pilus usher proteins FimD
and PapC were SurA-dependent OMPs [13]. Mutation in surA
results in accumulation of unfolded intermediates in the periplasm
[12] and activation of the sE stress-response system [12,14], which
includes transcription of the periplasmic chaperone/protease degP
[6]. More direct evidence of the involvement of SurA in OMP
trafficking through the periplasm has been provided by Silhavy and
colleagues. Mutations in surA were shown to be synthetically lethal
with those in degP or in skp, which encodes a distinct and structurally
unrelated periplasmic chaperone [15]. Subsequent studies in which
SurA was depleted in a graded fashion showed that SurA was the
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primary chaperone responsible for OMP transit, while Skp and
DegP likely can compensate to an extent when OMPs fall off the
SurA pathway. Further, SurA was shown to interact directly with
BamA in vivo [16].
The crystal structure of SurA from E. coli K-12, identical in
primary sequence to that of other E. coli strains (including UPEC)
and highly similar to those expressed by Salmonella, Shigella, and
Yersinia [17,18], was solved in 2002 [19]. The protein includes four
distinct structural domains: an N-terminal domain with no obvious
homology to other protein families, two parvulin-like PPIase
domains (herein denoted I and II), and a short C-terminal domain.
In the three-dimensional structure, the N and C-terminal domains
together form a ‘‘core module’’ that is completed by a strand from
PPIase domain I, while domain II extends away from this core
module [19]. In vitro, the chaperone preferentially binds peptide
sequences containing two aromatic residues separated by another
amino acid (Ar-X-Ar), a motif that is over-represented in integral
OM proteins of E. coli compared to proteins in other cellular
compartments [20–22]. Finally, other studies have suggested that
the chaperone activity of SurA localizes not to its two parvulin-like
PPIase domains, but to its N-terminal substrate-binding domain.
These studies relied on its interaction with non-native substrates,
namely protection of citrate synthase from aggregation and
binding to somatostatin [14,23]. In this study, we aimed to
investigate the components of SurA necessary for chaperone
action in a pathogenic strain of E. coli and using chromosomally
expressed, native SurA-dependent proteins. We interrogated SurA
function using in vivo phenotypes relevant to E. coli uropathogen-
esis, namely resistance to membrane-impermeable antimicrobials
and surface expression of the type 1 pilus usher FimD.
Materials and Methods
Bacterial strains and media
E. coli was grown in Luria-Bertani (LB) medium or Mueller-
Hinton medium as indicated (Difco, Becton-Dickinson, Sparks,
MD). UPEC strain UTI89 was recovered from the urine of a
patient with cystitis [24]; C600 is a laboratory E. coli K-12 strain
used for protein production. The UTI89 surA mutant was created
by insertional disruption as described [25]. A panel of SurA
domain constructs in the expression vector pQE30 was kindly
provided by Dr. Susanne Behrens [14]. The coding region of each
construct was amplified by high-fidelity PCR (Stratagene, La Jolla,
CA) incorporating an XbaI site into the reverse primer. PCR
products were digested with EcoRI and XbaI, and each resulting
fragment was then ligated into the expression vector pTRC99 (GE
Healthcare/Pharmacia, Piscataway, NJ). Empty vector (denoted
pEV) and vector encoding full-length, native SurA (called pDH23)
were included as controls where indicated. Expression was
induced by addition of isopropyl b-D-1-thiogalactopyranoside
(IPTG; Sigma, St. Louis, MO) at the indicated concentrations.
Fractionation and Western immunoblotting
For periplasm preparation, cultures of the indicated strains
grown in LB broth were harvested at mid-logarithmic phase, after
IPTG induction during the last 40 min of growth. Cell pellets were
resuspended in 20 mM Tris (pH 8.0) with 20% (w/v) sucrose;
EDTA was added to 5 mM and lysozyme to 80 mg/mL, and the
mixture was incubated on ice 20 min. MgCl2 was added to
25 mM and cell debris was pelleted by centrifugation. Superna-
tants (periplasms) were stored at 20uC until use. For preparation of
outer membranes, overnight static cultures were back-diluted with
LB broth to equivalent optical densities (at 600 nm), centrifuged
and the weighed cell pellets resuspended in 10 mM Tris (pH 8.0)
with 100 mg/mL each of DNase and RNase (Sigma, St. Louis,
MO). The suspensions were lysed in a French pressure cell
(14,000 psi) for two passages, and debris was removed by low-
speed centrifugation. Membranes were collected by ultracentrifu-
gation (33,0006 g for 80 min) and pellets resuspended in 5 mL of
50 mM Tris (pH 8.0) with 1% N-laurylsarcosine (Sigma). After
1 h at RT with gentle rocking, ultracentrifugation was repeated,
supernatants (representing inner membranes) were decanted and
the pellets (outer membranes) were resuspended in Tris buffer. For
detection of SurA variants, equal amounts of identically prepared
periplasmic fractions were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to
polyvinylidene difluoride membranes (PVDF; Millipore, Billerica,
MA). Full-length SurA with a 6-histidine tag was expressed in E.
coli strain C600 and purified by metal-affinity chromatography.
Antibodies directed against full-length SurA were raised in mice
using standard Freund’s adjuvant-based immunization and serum
collection techniques, according to a protocol approved by the
institutional Animal Studies Committee. Bound anti-SurA anti-
bodies were recognized with alkaline phosphatase-conjugated anti-
mouse IgG and visualized using BCIP/NBT substrate (both from
Sigma). For FimD immunoblotting, outer membrane fractions
were subjected to SDS-PAGE, transferred to PVDF membranes,
and overlaid with mouse antiserum to FimD (MedImmune,
Gaithersburg, MD). Bound anti-FimD antibodies were detected
with peroxidase-conjugated anti-mouse IgG (Sigma) and visualized
with CDP-Star substrate (Tropix Inc., Bedford, MA) and ECL
Hyperfilm (GE Healthcare/Amersham, Pittsburgh, PA). For
presentation, blots were scanned using an Epson 4470 scanner
and band intensities quantified with ImageJ software (National
Institutes of Health, Bethesda, MD). Data presented are
representative of multiple independent experiments.
Novobiocin growth assays
For disk diffusion assays, overnight cultures of the indicated
strains in Mueller-Hinton broth (containing selective antibiotic)
were subcultured, grown to equivalent optical densities, and
swabbed in a lawn on freshly prepared Mueller-Hinton agar plates
containing 0.01 mM IPTG. Filter paper disks containing 30 mg
novobiocin (Becton-Dickinson) were placed on the agar, and the
diameter of the zone of clearance was recorded after a second
overnight incubation at 37uC. For bacterial growth curves,
overnight cultures of the indicated strains were subcultured
1:200 into fresh LB broth (with antibiotics and IPTG) in wells of
a 24-well plate, then shaken at 37uC in a Synergy 2 multimode
microplate reader (Bio-Tek, Winooski, VT) with absorbance
readings at 600 nm recorded every 30 min.
In vitro hemagglutination (HA), binding and invasion
Type 1 pilus-dependent hemagglutination of guinea pig
erythrocytes (Colorado Serum Co., Denver, CO) was assayed in
96-well V-bottom plates as described previously (19). For binding
and invasion experiments, cultured 5637 human bladder epithelial
cells (ATCC HTB-9) were obtained from the American Type
Culture Collection (Manassas, VA) and grown in RPMI 1640
medium (Gibco/Invitrogen, Grand Island, NY) supplemented
with 10% fetal bovine serum (Sigma) at 37uC in a humidified
atmosphere of 95% air and 5% CO2. Two days prior to assay,
cells were detached with trypsin (0.05%) plus EDTA (0.02%),
centrifuged, resuspended in fresh medium, and allocated to wells
of sterile 24-well tissue culture plates. On the day of assay,
confluent monolayers were washed once with sterile PBS, and
fresh medium was applied prior to infection with 107 CFU/mL of
the indicated strains. Quantitation of cell-associated bacteria and
SurA in Uropathogenic E. coli
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invaded bacteria (via gentamicin protection) was performed as
previously described [26].
Statistical analysis
Two-tailed Student’s T-tests were used for comparison of
numerical data. For binding and invasion assays, relative binding
and invasion by UPEC expressing SurA variants was reported as
proportional to wild-type UPEC in each experiment, and the
aggregate data were presented and statistically compared. A p
value of less than 0.05 was considered statistically significant.
Results and Discussion
Expression of SurA domain variants in UPEC
The set of domain constructs used in this study is shown in
Figure 1A. For our studies, we excluded constructs that encoded the
N-terminal domain but lacked the C-terminal domain, because the
resulting polypeptides were previously found to be unstable ([14] and
S. Behrens, personal communication). The remaining domain
constructs were migrated to a different expression system and host
strain than that earlier described [14]; therefore, we first evaluated
expression of the domain variants in a uropathogenic strain of E. coli.
Periplasms were prepared from UTI89 surA::kan complemented with
full-length surA (on plasmid pDH23) or each of these domain
constructs (induced with 0.01 mM IPTG). The periplasms were
subjected to SDS-PAGE and immunoblotting using mouse
antiserum raised against full-length SurA. Constructs containing
the N- and C-terminal domains, with and without the PPIase
domains (i.e., N+C, N+I+C, N+II+C, and full-length SurA) were all
detectable at predicted sizes by Western blotting with mouse
polyclonal antiserum raised against full-length SurA (Figure 1B).
The combination of domains I+II was also detected readily; of these
individual domains, domain II was more prominent than domain I
on multiple blots. These results are generally consistent with those
found in the constructs’ original expression system in E. coli K-12
[14], with the exception that domain I appears less stable than
domain II when expressed alone in the uropathogen. Steady-state
periplasmic levels of the SurA variants with induction at higher
IPTG concentrations (up to 0.1 mM) were not significantly different
(data not shown).
Membrane permeability and antibiotic resistance
To determine general effects on the membrane of UPEC during
complementation of the surA mutant with the SurA domain
constructs, we assessed growth in the presence of novobiocin, a
hydrophobic aminocoumarin antibiotic and inhibitor of DNA gyrase
[27] that normally does not penetrate the Gram-negative cell
envelope. We have previously demonstrated that lack of SurA
imparts susceptibility to novobiocin in E. coliK-12 [13]. As measured
by disk diffusion with 11-mm, 30-mg novobiocin filter paper disks,
growth inhibition of the UTI89 surAmutant was significantly greater
than that of wild-type UTI89 (Figure 2A). Complementation of the
mutant with constructs containing the N- plus C-terminal domains
of SurA restored wild-type resistance; inclusion of domain I or II did
not significantly alter this phenotype. In contrast, domains I or II
alone or in combination, though stably expressed, did not restore
novobiocin resistance (p,0.001 versus wild type). We next
proceeded to examine novobiocin susceptibility in an alternative
way, namely the growth of the same strains in LB broth culture
containing 10 mg/mL of novobiocin. Under these conditions, the N
and C-terminal domains together substantially restored novobiocin
resistance to the surA mutant (Figure 2B), and addition of domain I
(but not domain II) augmented growth (p,0.05). The broth culture
experiments were therefore more sensitive in detecting a role for
domain I; such a role might relate either to stability of the SurA ‘‘core
module’’ (as suggested by Figure 1B) or perhaps to aspects of SurA
function, such as substrate binding.
Type 1 pilus-dependent phenotypes of UPEC
The capacity of UPEC to bind and invade the bladder
epithelium is conferred by type 1 pili and, more specifically, by
the mannose-sensitive type 1 tip adhesin FimH [26]. Our recent
Figure 1. Complementation of the UPEC surAmutant with SurA
domain constructs. (A) Schematic representation of the domains of
mature periplasmic SurA, with amino acid residues (at top) numbered
as in the synthesized polypeptide. Notation is adapted from reference 2.
Constructs marked with an asterisk, containing the N-terminal but not
the C-terminal domain, do not express stable protein variants ([ref. 14]
and data not shown). Letters at right denote lane position in the blot in
the lower panel. (B) Expression of domain variants in UPEC, as assessed
by immunoblot of periplasmic extracts using mouse antiserum raised
against full-length SurA with a 6-histidine tag. Approximate molecular
masses are shown to the left. Lane a is from wild-type UTI89, b from the
UTI89 surA mutant, and subsequent lanes from the UTI89 surA mutant
complemented with plasmids expressing the following constructs (with
predicted band sizes): c, empty vector; d, pDH23 (full-length SurA,
46kD); e, pSurAN+C (24 kD); f, pSurAN+I+C (34 kD); g, pSurAN+II+C
(32 kD); h, pSurAI+II (22 kD); i, pSurAI (12 kD); j, pSurAII (11 kD). Bands
representing expressed variants are denoted with arrowheads.
doi:10.1371/journal.pone.0003359.g001
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work demonstrated that inactivation of surA in E. coli K-12 or in
UTI89 resulted in significantly decreased piliation, corresponding
with a decrement in steady-state levels of the type 1 pilus usher
FimD in the OM [13,28]. We applied similar analyses to the
UTI89 surA mutant complemented with SurA domain variants.
First we assayed the agglutination of guinea pig erythrocytes, an in
vitro phenotype dependent on FimH, by UTI89 expressing the
SurA variants. Consistent with our previous results, loss of SurA
led to a significant reduction in hemagglutination (HA) titer
(Figure 3), and the residual HA was inhibited by the addition of
2% methyl-a-D-mannopyranoside (data not shown). Complemen-
tation with full-length SurA or with the N- plus C-terminal
domains substantially restored the HA titer. Inclusion of domain I
or II did not provide an additive effect on the HA titer, and
domains I and/or II alone provided no complementation. For
N+C, N+I+C, and N+II+C, increases in the concentration of
inducer (to 0.1 mM IPTG) caused piliation levels and HA titers to
decrease (data not shown), suggesting that accumulation of
imperfect variants in the periplasm or occupation of other
chaperone or periplasmic stress-response systems had a detrimen-
tal effect on pilus assembly and presentation.
To more specifically investigate the relevant type 1-dependent
functions of the SurA variant strains, we next assayed the binding
and invasion of cultured human bladder epithelial cells by UPEC
expressing the SurA variants. Confluent monolayers of 5637
human bladder epithelial cells were infected with each strain;
binding was evaluated after washing and homogenization of the
monolayers, and invasion was assessed by gentamicin protection
Figure 2. Restoration of novobiocin resistance in UTI89 by SurA variants. (A) Susceptibility to novobiocin is reported as the diameter of the
zone of inhibition around 11-mm novobiocin disks after overnight incubation on Mueller-Hinton agar. Thus, wild-type UTI89 (leftmost bar) grows up
to the disk edge (disk diameter indicated by gray line), and the surA mutant is susceptible to novobiocin under these conditions. Resistance is
complemented by full-length SurA or the N+C domains. Domains I and/or II alone do not restore novobiocin resistance (*p,0.001 vs. UTI89); either
domain I or II, when included with the N+C domains, bolsters resistance by a nonsignificant amount. Results represent the average of three separate
experiments. (B) Growth of the indicated strains in LB broth containing 10 mg/mL novobiocin. The surA mutant is nonviable (black circles), and
complementation with full-length SurA (on pDH23; gray squares) restores growth equivalent to wild-type UTI89 (black diamonds). Under these
conditions, the N+C variant incompletely rescues novobiocin resistance (black triangles), and a small but significant contribution of domain I to
novobiocin resistance is revealed (gray triangles; p,0.05 versus N+C from 2 to 8 h). Absent growth of the surA mutant complemented with empty
vector, pSurAI, pSurAII, or pSurAII was indistinguishable from the surA mutant itself; these curves were omitted from the graph for clarity.
doi:10.1371/journal.pone.0003359.g002
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[29]. Consistent with our prior results [28], there was a sharp
decrement in epithelial binding by the surA mutant when compared
with wild-type UTI89, and this defect was complemented by
provision of full-length surA in trans (Figure 4). Domain constructs
encoding both the N- and C-terminal domains of SurA substantially
but incompletely restored both binding and invasion (p,0.04 for
binding and invasion versus the surA mutant, either alone or with
empty vector; p,0.0001 for binding and p,0.002 for invasion
versus wild type). The addition of either domain I or II to the N- plus
C-terminal domains had no significant impact on binding but
conferred significant increases in invasion (p,0.01 for each
comparison versus N+C). Binding and invasion by UTI89 expressing
SurA variants including only domains I and/or II (without the core
module) were indistinguishable from the surA mutant.
Steady-state production of FimD
Our previous data suggested that the type 1 pilus usher FimD is
a SurA-dependent OM protein, and that failed maturation of this
usher underlies defective piliation in surA mutants. Therefore, we
examined the steady-state levels of FimD in UTI89 and the surA
mutant expressing the SurA domain variants by Western blotting
of outer membranes harvested from these strains. Consistent with
prior results, disruption of surA led to a notable decrement in the
presentation of FimD, and this was restored by complementation
with full-length SurA (Figure 5). Mirroring the invasion data,
domains N+C substantially restored FimD presence in the OM,
and addition of domain I slightly augmented FimD levels. The
PPIase domains alone contributed no support of FimD maturation
in the OM. This experiment provides further evidence that the
defect in type 1 piliation of surA mutants is due to failed maturation
of FimD. In addition, our combined studies of the relationship
between SurA and the type 1 pilus assembly system indicate that
pilus production in UPEC relies primarily on activity of the core
module of SurA and suggest a contribution from the PPIase
domain(s), particularly domain I. Finally, we conclude that type 1
piliation and pilus-dependent functions in UPEC are proportional
to the amount of usher present in the OM, suggesting that usher
maturation might represent a means by which the bacterial cell
can regulate the presentation of pili under different conditions.
Figure 3. Hemagglutination (HA) by SurA domain-comple-
mented UTI89. Uniform suspensions of the indicated strains were
mixed with a series of two-fold dilutions of guinea pig erythrocytes, and
the overnight HA titer is shown. HA is substantially complemented by
full-length SurA or any of the N+C-containing variants, while domains I
and II (alone or in combination) fail to complement the HA defect of the
surA mutant (*p,0.01 versus WT). Results are representative of three
separate experiments.
doi:10.1371/journal.pone.0003359.g003
Figure 4. Binding and invasion of cultured bladder epithelial
cells by SurA domain-complemented UTI89. Relative binding and
invasion capacities are shown as a proportion of wild-type UTI89
binding and invasion; results for each strain represent the aggregate of
at least three independent experiments. Binding and invasion are
significantly reduced in the surA mutant. The three variants containing
the N+C domains substantially restored binding and invasion (p,0.04
versus surA mutant), but below wild-type levels (p,0.0001 versus WT
for binding; p,0.002 for invasion). Addition of domain I or II to N+C was
associated with a significant increase in invasion capacity (p,0.01). The
three SurA variants containing only domains I and/or II failed to restore
these type 1 pilus-dependent functions (p,0.0001 versus WT for both
binding and invasion).
doi:10.1371/journal.pone.0003359.g004
Figure 5. Usher levels in the OM. Steady-state levels of FimD in total
membrane extracts from the indicated strains were determined by SDS-
PAGE followed by Western immunoblotting (upper panel) using a
mouse antiserum to FimD. Quantitation of band intensity is shown in
the lower panel, expressed relative to wild type. Consistent with
previous results, FimD presence is sharply reduced in the surA mutant.
FimD is restored upon complementation with full-length SurA. The N+C
variant substantially restores FimD stability, and addition of domain I
(but not domain II) augments this phenotype. Domains I and/or II alone
provide minimal chaperone function. Cross-reacting bands are included
in the figure to demonstrate overall protein loading.
doi:10.1371/journal.pone.0003359.g005
SurA in Uropathogenic E. coli
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Bacterial systems supporting the maturation, assembly, and
insertion of outer membrane proteins are of critical importance to
membrane integrity and function, including filtering, permeability,
and secretion. In recent years much has been learned about the
trafficking and assembly of porins into the OM. SurA appears to
key the periplasmic transit of nascent, monomeric OMP species,
delivering these to the OMP assembly complex anchored by
BamA, itself an OMP. Indeed, recent data demonstrate a direct
biochemical interaction of SurA with BamA in vivo [16]. Putative
OMP sequences targeted for binding by SurA have been identified
[20,22], and the present study augments earlier findings regarding
the portions of SurA critical for its chaperoning of OMPs
[14,23,30]. Despite these advances, the spectrum of SurA-
dependent OMPs is not precisely defined. While structural details
of SurA interaction with model peptides have recently been
published [30], similar demonstration of its binding to one or more
in vivo OMP substrates is needed for a more complete
understanding of its mechanism of action. Our ongoing studies
aim to delineate the range of SurA-dependent proteins, to
demonstrate direct SurA-substrate interactions, and to interrogate
the structural details of the chaperone-substrate relationship.
Knowledge at a molecular level of the mechanisms of SurA
function will also inform the development of small-molecule
inhibitors of this important and conserved chaperone. Of primary
interest, such an inhibitor might prove a valuable anti-virulence
compound against Gram-negative pathogens. As a primary
example, SurA provides pleiotropic support to virulence of
uropathogenic E. coli. We have shown here that SurA keys type
1 piliation, a primary determinant in cystitis; but SurA-dependent
proteins also support the intracellular phenotypes of UPEC ([28]
and unpublished data) and the local suppression of epithelial
proinflammatory cytokines [25]. Beyond E. coli, SurA is conserved
in other Gram-negative pathogens, such as Salmonella, Yersinia, and
Shigella; and a Salmonella surA mutant was attenuated after oral
inoculation in mice [31]. In the laboratory, a genetic method for
incremental control of surA expression (and thus SurA function)
has recently been demonstrated [16]. However, an available
inhibitor would simplify this control, offering broad potential
applications in the study of Gram-negative envelope biology and
outer membrane biogenesis.
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